文献速递角膜与眼表疾病

超薄DSAEK与DMEK术后角膜高阶像差的随机临床试验比较

Corneal Higher-Order Aberrations in Descemet Membrane Endothelial Keratoplasty versus Ultrathin DSAEK in the Descemet Endothelial Thickness Comparison Trial: A Randomized Clinical Trial.
PubMed 文献 · Ophthalmology · 2019-02-16

本研究为患者与结果设盲的随机对照试验,纳入Fuchs内皮营养不良或假晶状体大疱性角膜病变患者,比较超薄DSAEK与DMEK术后角膜高阶像差(HOA)。结果显示DMEK术后后表面彗差和总HOA显著低于超薄DSAEK,且DMEK较术前降低而后表面总HOA,超薄DSAEK较术前升高;术后6和12个月后表面总HOA与BSCVA相关。

要点

  • DMEK术后后角膜表面彗差和总HOA显著低于超薄DSAEK。
  • DMEK较术前降低后表面总HOA,超薄DSAEK较术前升高。
  • 术后6和12个月后表面总HOA与BSCVA相关。

核心结论

  • DMEK较超薄DSAEK产生更少的后角膜高阶像差。
  • DMEK较术前降低而后表面总HOA,超薄DSAEK较术前升高。
  • 后表面总HOA与术后6和12个月视力相关,可能解释DMEK术后更佳视力。

研究设计与样本

  • 患者与结果设盲的随机对照临床试验。
  • 纳入Fuchs内皮营养不良或假晶状体大疱性角膜病变且适合DMEK或超薄DSAEK的患者。
  • 术前及术后3、6、12个月用Scheimpflug成像测量角膜前、后表面HOA。

主要发现

  • 术后3、6、12个月,DMEK后表面彗差(P≤0.003)和总HOA(P≤0.001)显著低于超薄DSAEK(4.0和6.0mm光学区)。
  • 术后3、6或12个月,DMEK后表面三叶草(P≤0.034)、次级散光(P≤0.042)和四叶草(P≤0.045)低于超薄DSAEK(4.0或6.0mm光学区)。
  • 术后各时间点前表面HOA在DMEK与超薄DSAEK间无显著差异。
  • 较基线,超薄DSAEK后表面总HOA在3、6、12个月增加(P≤0.036),DMEK在6、12个月降低(P≤0.044)。
  • 术后6和12个月,后表面总HOA与BSCVA相关(ρ≤0.635,P≤0.001;4.0和6.0mm光学区)。

关键数值与推荐

  • 后表面彗差DMEK低于超薄DSAEK:P≤0.003(术后3、6、12个月,4.0和6.0mm光学区)。
  • 后表面总HOADMEK低于超薄DSAEK:P≤0.001(术后3、6、12个月,4.0和6.0mm光学区)。
  • 后表面三叶草P≤0.034、次级散光P≤0.042、四叶草P≤0.045,DMEK低于超薄DSAEK。
  • 超薄DSAEK后表面总HOA较基线增加P≤0.036,DMEK降低P≤0.044。
  • 术后6和12个月后表面总HOA与BSCVA相关:ρ≤0.635,P≤0.001。

临床怎么用

  • 选择内皮移植术式时可考虑DMEK后表面高阶像差更小、视觉质量可能更优。
  • 术后评估视觉质量可关注后表面总HOA,其与6和12个月BSCVA相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare corneal higher-order aberrations (HOA) after ultrathin Descemet stripping automated endothelial keratoplasty (DSAEK) and Descemet membrane endothelial keratoplasty (DMEK). DESIGN: Patient- and outcome-masked randomized controlled clinical trial. PARTICIPANTS: Patients with damaged or diseased endothelium from Fuchs endothelial dystrophy or pseudophakic bullous keratopathy who were good candidates for DMEK or ultrathin DSAEK. METHODS: Corneal anterior and posterior surface HOA were measured with Scheimpflug imaging before surgery and at 3, 6, and 12 months after surgery. HOA after ultrathin DSAEK and DMEK were compared; correlation was performed between best spectacle-corrected visual acuity (BSCVA) and HOA at each time point. MAIN OUTCOME MEASURES: Higher-order aberrations of the anterior and posterior cornea, expressed as the root mean square deviation from a best fit sphere reference surface. RESULTS: At 3, 6, and 12 months after surgery, the posterior corneal surface had significantly less coma (P ≤ 0.003) and total HOA (P ≤ 0.001) in DMEK compared with ultrathin DSAEK (4.0- and 6.0-mm OZ). Posterior trefoil (P ≤ 0.034), secondary astigmatism (P ≤ 0.042), and tetrafoil (P ≤ 0.045) were lower in DMEK than ultrathin DSAEK at 3, 6, or 12 months (either 4.0- or 6.0-mm OZ). There were no significant differences in anterior surface HOA between DMEK and ultrathin DSAEK at any post-surgical time. Compared with baseline, total posterior HOA was increased (P ≤ 0.036) in ultrathin DSAEK at 3, 6, and 12 months, in contrast to DMEK, where it was decreased (P ≤ 0.044) at 6 and 12 months (4.0- or 6.0-mm OZ, or both). At 6 and 12 months, posterior corneal total HOA correlated with BSCVA (ρ ≤ 0.635, P ≤ 0.001; 4.0- and 6.0-mm OZ). There were no moderate or strong correlations between anterior or combined corneal surface HOA at any time point after surgery. CONCLUSIONS: Descemet membrane endothelial keratoplasty results in less posterior corneal HOA compared with ultrathin DSAEK. Descemet membrane endothelial keratoplasty decreases and ultrathin DSAEK increases posterior corneal HOA compared with presurgical values. Total posterior corneal HOA correlates with 6- and 12-month postoperative visual acuity and may account for the better visual acuity observed after DMEK.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Duggan MJ, Rose-Nussbaumer J, Lin CC, et al. Corneal Higher-Order Aberrations in Descemet Membrane Endothelial Keratoplasty versus Ultrathin DSAEK in the Descemet Endothelial Thickness Comparison Trial: A Randomized Clinical Trial. Ophthalmology. 2019. PMID: 30776384. doi:10.1016/j.ophtha.2019.02.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。